A Reduced-Incision Option for Patients
TransEnterix is a medical device company that is focused on developing technologies that enable single-incision abdominal surgery. While traditional surgeries may require multiple incisions or a larger open surgical site, single incision surgery allows surgeons to perform some procedures through one small abdominal incision.
There are currently many options available for laparoscopic surgery. As with any surgical procedure, there are risks. Patients should speak with their doctors about those risks and what they should expect individually in terms of the surgery, incisions, and recovery time.
The SurgiBot® System is currently in development and has not yet been cleared by the FDA for sale in the United States or by other regulatory authorities for sale outside the United States.